Skip to content

Lion's mane mushroom and perceived stress: grade C

Limited evidence. Direction: No effect.

C LimitedIndustry-fundedSubjective outcome onlyShort-term only

Why this grade

Rubric condition met: C: small or pilot studies with within-group or uncontrolled signals; the largest controlled trial did not report lion's mane alone beating placebo

In healthy young adults, 28 days of 1.8 g a day gave only a non-significant trend towards lower stress (p = 0.051). In 84 young women with stress or anxiety, a lion's mane and reishi blend lowered the primary anxiety score relative to lion's mane alone, and all groups including placebo improved. Lower mood-questionnaire scores were reported within the lion's mane group in a 4-week trial in 30 women and in an uncontrolled 8-week study in a clinical population whose participants were also on a low-calorie diet, so supplement and diet effects cannot be separated.

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)20102015202020252030RCTUncontrolled pilo…Smith 2026, 2026: RCT, n = 84, result not recordedVigna 2019, 2019: uncontrolled pilot study (no placebo group), 8 weeks, n = 77, result not recordedDocherty 2023, 2023: RCT, n = 41, result not recordedNagano 2010, 2010: RCT, n = 30, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Nagano 20102010RCT30result not recorded
Vigna 20192019uncontrolled pilot study (no placebo group), 8 weeks77result not recorded
Docherty 20232023RCT41result not recorded
Smith 20262026RCT84result not recorded

Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?

Vigna L, Morelli F, Agnelli GM. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers? Evid Based Complement Alternat Med, 2019. PMID 31118969

Result not recorded
Design
Uncontrolled pilot study (no placebo group), 8 weeks
Sample
n = 77
Population
Adults with overweight or obesity and a mood or sleep disorder or binge eating, on a low-calorie diet (clinical population)
Funding
Italian Ministry of Education, University and Research; University of Pavia (Crossref); supplement provided by A.V.D. Reform s.r.l.

Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake.

Nagano M, Shimizu K, Kondo R. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake Biomed Res, 2010. PMID 20834180

Result not recorded
Design
Randomized, placebo-controlled trial (4 weeks)
Sample
n = 30
Population
Women, studied for menopausal symptoms, mood and sleep quality
Funding
not stated

The effects of four-week supplementation of Lion's mane and a Lion's mane and Reishi blend on prioritised mood and wellbeing measures in young women.

Smith EF, Docherty S. The effects of four-week supplementation of Lion's mane and a Lion's mane and Reishi blend on prioritised mood and wellbeing measures in young women Front Nutr, 2026. PMID 42978868

Result not recorded
Design
Randomized, double-blind, placebo-controlled three-arm parallel trial (28 days)
Sample
n = 84
Population
Women aged 18-26 experiencing subjective stress and/or anxiety
Funding
Internal funding from Northumbria University; investigational products provided by Sempera Organics

The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.

Docherty S, Doughty FL, Smith EF. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study Nutrients, 2023. PMID 38004235

Result not recorded
Design
Randomized, double-blind, placebo-controlled parallel-group pilot trial (acute and 28-day)
Sample
n = 41
Population
Healthy adults aged 18-45
Funding
No external funding; investigational product provided by Sempera Organics (manufacturer), which had no role in design, analysis or writing

Search and history

Search (): (Hericium erinaceus[tiab] OR "lion's mane"[tiab]) AND (mood[tiab] OR stress[tiab] OR depress*[tiab] OR anxiety[tiab] OR sleep[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR trial[ti])

  • Graded C (proposed): Proposed in the monograph draft
  • C to C (proposed): Editor review ed-2026-11-11: C kept, direction changed from benefit to none: no controlled trial showed lion's mane alone beating placebo; industry-funded added because 3 of 4 studies used manufacturer-donated product (policy 3.3).
  • C to C (approved): Editor sign-off November 13, 2026: grade matches the editor-approved final page